Updates are available Correction dated 2019-06-05
Click to view Correction: https://doi.org/10.1038/s41593-019-0402-7
-
Authors
,
Pasman, Joëlle A. https://orcid.org/0000-0001-7558-0482
,
,
Verweij, Karin J. H.
Gerring, Zachary
Stringer, Sven https://orcid.org/0000-0003-3115-8532
Sanchez-Roige, Sandra
Treur, Jorien L.
Abdellaoui, Abdel
Nivard, Michel G. https://orcid.org/0000-0003-2015-1888
Baselmans, Bart M. L.
Ong, Jue-Sheng https://orcid.org/0000-0002-6062-710X
Ip, Hill F. https://orcid.org/0000-0003-1991-5019
van der Zee, Matthijs D.
Bartels, Meike https://orcid.org/0000-0002-9667-7555
Day, Felix R. https://orcid.org/0000-0003-3789-7651
Fontanillas, Pierre
Elson, Sarah L.
de Wit, Harriet
Davis, Lea K. https://orcid.org/0000-0001-5143-2282
MacKillop, James https://orcid.org/0000-0003-4118-9500
Derringer, Jaime L.
Branje, Susan J. T.
Hartman, Catharina A.
Heath, Andrew C.
van Lier, Pol A. C.
Madden, Pamela A. F.
Mägi, Reedik
Meeus, Wim
Montgomery, Grant W. https://orcid.org/0000-0002-4140-8139
Oldehinkel, A. J. https://orcid.org/0000-0003-3925-3913
Pausova, Zdenka
Ramos-Quiroga, Josep A.
Paus, Tomas
Ribases, Marta https://orcid.org/0000-0003-1039-1116
Kaprio, Jaakko https://orcid.org/0000-0002-3716-2455
Boks, Marco P. M. https://orcid.org/0000-0001-6163-7484
Bell, Jordana T.
Spector, Tim D.
Gelernter, Joel https://orcid.org/0000-0002-4067-1859
Boomsma, Dorret I.
Martin, Nicholas G.
MacGregor, Stuart https://orcid.org/0000-0001-6731-8142
Perry, John R. B.
Palmer, Abraham A. https://orcid.org/0000-0003-3634-0747
Posthuma, Danielle https://orcid.org/0000-0001-7582-2365
Munafò, Marcus R. https://orcid.org/0000-0002-4049-993X
Gillespie, Nathan A.
Derks, Eske M. https://orcid.org/0000-0002-6292-6883
Vink, Jacqueline M. https://orcid.org/0000-0003-3910-3528
- License Information
-
More Information
Article History
Received: 12 January 2018
Accepted: 28 May 2018
First Online: 27 August 2018
Change Date: 5 June 2019
Change Type: Correction
Change Details: Several occurrences of the word ‘schizophrenia’ have been re-worded as ‘liability to schizophrenia’ or ‘schizophrenia risk’, including in the title, which should have been “GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability,” as well as in Supplementary Figures 1–10 and Supplementary Tables 7–10, to more accurately reflect the findings of the work.
Competing interests
: P.F., S.L.E. and members of the 23andMe Research Team are employees of 23andMe Inc. J.A.R.-Q. was on the speakers’ bureau and/or acted as consultant for Eli Lilly, Janssen-Cilag, Novartis, Shire, Lundbeck, Almirall, BRAINGAZE, Sincrolab and Rubió in the last 5 years. He also received travel awards (air tickets and hotel) for taking part in psychiatric meetings from Janssen-Cilag, Rubió, Shire and Eli Lilly. The Department of Psychiatry chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last 5 years: Eli Lilly, Lundbeck, Janssen- Cilag, Actelion, Shire, Ferrer and Rubió.
